Cookies help us deliver our services. By using our services, you agree to our use of cookies.
Learn more
OK
Skip to main content (Press Enter).
Sign In
Skip auxiliary navigation (Press Enter).
Contact Us
Skip main navigation (Press Enter).
Toggle navigation
Search Options
About
What is the AMS
AMS International Scientific Committee
AMS Educational Executive Committee
AMS Ambassadors
Upcoming Events
Videos & Webinars
International Events
Become a Speaker
Videos On Demand
Education 365
Features
AMS Features
Blogs
Industry
Industry Partners
Become a Sponsor
Features
Blogs
Blog Viewer
Blogs
Biologics for patients affected by hidradenitis suppurativa in the COVID-19 era: data from a referral center of Southern Italy
By
Aesthetic Multispecialty Society
posted
May 25, 2020 10:53 AM
0
Recommend
.
0 comments
0 views
Related Content
Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?
Aesthetic Multispecialty Society
Added Jun 19, 2020
Blog Entry
Delay Surgery By 7 Weeks After Covid Diagnosis: Study
Aesthetic Multispecialty Society
Added Apr 21, 2021
Blog Entry
New Data Captures Millennial Spending Surge on Aesthetic Treatments
Aesthetic Multispecialty Society
Added Jun 22, 2021
Blog Entry
The impact of COVID-19 pandemics on dermatologic surgery: real-life data from the Italian Red-Zone
Aesthetic Multispecialty Society
Added Jul 07, 2020
Blog Entry
2020 global survey from ISAPS sees significant changes in aesthetic procedures during pandemic
Aesthetic Multispecialty Society
Added Feb 02, 2022
Blog Entry
Permalink
© 2022 AMS, Aesthetic Multispecialty Society. All Rights Reserved.
Powered by Higher Logic